Innovative Eyewear Files S-1 for Public Offering

TL;DR

Innovative Eyewear is going public, filing S-1 on 5/31/24. Get ready for some new specs!

AI Summary

Innovative Eyewear Inc. filed an S-1 form on May 31, 2024, indicating plans for a public offering. The company, based in Miami, Florida, operates in the ophthalmic goods sector. Financial data for the periods ending December 31, 2021, 2022, and 2023, as well as the first quarter of 2024, are included in the filing.

Why It Matters

This S-1 filing signals Innovative Eyewear Inc.'s intention to raise capital through the public markets, which could fund expansion or new product development in the competitive eyewear industry.

Risk Assessment

Risk Level: medium — As a company pursuing an IPO, Innovative Eyewear faces inherent risks related to market reception, competition, and execution of its business plan.

Key Numbers

• 2024 Q1 — Financial Period (Represents the first quarter of 2024 for which financial data is provided.)
• 2023-12-31 — Fiscal Year End (Indicates the end of the fiscal year for which financial data is reported.)
• 2022-12-31 — Fiscal Year End (Indicates the end of the fiscal year for which financial data is reported.)
• 2021-12-31 — Fiscal Year End (Indicates the end of the fiscal year for which financial data is reported.)

Key Players & Entities

• Innovative Eyewear Inc. (company) — Filer of the S-1 registration statement.
• Miami, Florida (location) — Location of Innovative Eyewear Inc.'s business address.
• 3851 (industry_code) — Standard Industrial Classification code for Ophthalmic Goods.
• May 31, 2024 (date) — Date the S-1 filing was submitted.

FAQ

Key Financial Figures

• $0.00001 — 3,782 shares of common stock, par value $0.00001 per share, of Innovative Eyewear, Inc.
• $0.244 — stor Warrants") at an exercise price of $0.244 per share originally issued by us on Ma
• $0.305 — pril Warrants") at an exercise price of $0.305 per share originally issued by us on Ma
• $0.475 — stor Warrants") at an exercise price of $0.475 per share originally issued by us on Ma
• $0.5938 — the "Warrants") at an exercise price of $0.5938 per share originally issued by us on Ma
• $0.95 — rted sale price of our common stock was $0.95 per share. Following effectiveness of
• $35.2 billion — eyewear in the U.S. is projected to be $35.2 billion in 2024. The market for digital assista
• $4.5 billion — rapidly worldwide, and is projected at $4.5 billion in revenue in 2023. We view the popular
• $249 M — e audio quality at a higher list price ($249 MSRP) than Lucyd Lyte 2.0 ($199). However
• $199 — price ($249 MSRP) than Lucyd Lyte 2.0 ($199). However, Bose has recently announced
• $329 — e Bluetooth eyewear space, offered at a $329 - $389 list price. Not available direct
• $389 — ooth eyewear space, offered at a $329 - $389 list price. Not available directly from
• $149 — and our glasses are more affordable at $149 - $199. Snapchat Spectacles . This is

Filing Documents

• innovativeeye_s1.htm (S-1) — 1788KB
• innovativeeye_ex5-1.htm (EX-5.1) — 11KB
• innovativeeye_ex23-1.htm (EX-23.1) — 3KB
• innovativeeye_ex107.htm (EX-FILING FEES) — 23KB
• img_001.jpg (GRAPHIC) — 23KB
• img_002.jpg (GRAPHIC) — 42KB
• fin_001.jpg (GRAPHIC) — 4KB
• fin_002.jpg (GRAPHIC) — 3KB
• ex5-1_001.jpg (GRAPHIC) — 10KB
• 0001829126-24-003896.txt ( ) — 6847KB
• lucy-20240331.xsd (EX-101.SCH) — 45KB
• lucy-20240331_cal.xml (EX-101.CAL) — 78KB
• lucy-20240331_def.xml (EX-101.DEF) — 171KB
• lucy-20240331_lab.xml (EX-101.LAB) — 310KB
• lucy-20240331_pre.xml (EX-101.PRE) — 318KB
• innovativeeye_s1_htm.xml (XML) — 798KB

Use of Proceeds

Use of Proceeds 40 Determination of Offering Price 41 Market Information for Common Stock and Dividend Policy 42

Management's Discussion and Analysis of Financial Condition and Results of Operation

Management's Discussion and Analysis of Financial Condition and Results of Operation 43

Business

Business 57 Management 79

Executive Compensation

Executive Compensation 83 Certain Relationships and Related Transactions 90

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters 92

Description of Securities Being Registered

Description of Securities Being Registered 94 Selling Stockholders 97 Plan of Distribution 99 Experts 101 Legal Matters 101 Where You Can Find More Information 101 Index to Financial Statements F-1 i Table of Contents Please read this prospectus carefully. It describes our business, our financial condition and our results of operations. We have prepared this prospectus so that you will have the information necessary to make an informed investment decision. You should rely only on the information contained in this prospectus. We have not authorized anyone to provide you with any information or to make any representations about us, the securities being offered pursuant to this prospectus or any other matter discussed in this prospectus, other than the information and representations contained in this prospectus. If any other information or representation is given or made, such information or representation may not be relied upon as having been authorized by us. The information contained in this prospectus is accurate only as of the date of this prospectus, regardless of the time of delivery of this prospectus or of any sale of our common stock. Neither the delivery of this prospectus nor any distribution of securities in accordance with this prospectus shall, under any circumstances, imply that there has been no change in our affairs since the date of this prospectus. This prospectus will be updated and made available for delivery to the extent required by the federal securities laws. We further note that the representations, warranties and covenants made by us in any document that is filed as an exhibit to the registration statement of which this prospectus is a part were made solely for the benefit of the parties to such agreement, including, in some cases, for the purpose of allocating risk among the parties to such agreements, and should not be deemed to be a representation, warranty or covenant to you. Moreover, such representat

View Full Filing

View this S-1 filing on SEC EDGAR